JP2020531530A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531530A5 JP2020531530A5 JP2020511364A JP2020511364A JP2020531530A5 JP 2020531530 A5 JP2020531530 A5 JP 2020531530A5 JP 2020511364 A JP2020511364 A JP 2020511364A JP 2020511364 A JP2020511364 A JP 2020511364A JP 2020531530 A5 JP2020531530 A5 JP 2020531530A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- salt
- composition according
- item
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023121658A JP2023129623A (ja) | 2017-08-22 | 2023-07-26 | アルキル鎖修飾イミダゾキノリンtlr7/8アゴニスト化合物およびその使用 |
| JP2025083816A JP2025131620A (ja) | 2017-08-22 | 2025-05-20 | アルキル鎖修飾イミダゾキノリンtlr7/8アゴニスト化合物およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762548848P | 2017-08-22 | 2017-08-22 | |
| US62/548,848 | 2017-08-22 | ||
| PCT/US2018/047323 WO2019040491A1 (en) | 2017-08-22 | 2018-08-21 | MODIFIED ALKYL CHAIN IMIDAZOQUINOLINE TLR7 / 8 AGONIST COMPOUNDS AND USES THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023121658A Division JP2023129623A (ja) | 2017-08-22 | 2023-07-26 | アルキル鎖修飾イミダゾキノリンtlr7/8アゴニスト化合物およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020531530A JP2020531530A (ja) | 2020-11-05 |
| JP2020531530A5 true JP2020531530A5 (cg-RX-API-DMAC7.html) | 2021-09-16 |
| JP7386536B2 JP7386536B2 (ja) | 2023-11-27 |
Family
ID=63638354
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511364A Active JP7386536B2 (ja) | 2017-08-22 | 2018-08-21 | アルキル鎖修飾イミダゾキノリンtlr7/8アゴニスト化合物およびその使用 |
| JP2023121658A Pending JP2023129623A (ja) | 2017-08-22 | 2023-07-26 | アルキル鎖修飾イミダゾキノリンtlr7/8アゴニスト化合物およびその使用 |
| JP2025083816A Pending JP2025131620A (ja) | 2017-08-22 | 2025-05-20 | アルキル鎖修飾イミダゾキノリンtlr7/8アゴニスト化合物およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023121658A Pending JP2023129623A (ja) | 2017-08-22 | 2023-07-26 | アルキル鎖修飾イミダゾキノリンtlr7/8アゴニスト化合物およびその使用 |
| JP2025083816A Pending JP2025131620A (ja) | 2017-08-22 | 2025-05-20 | アルキル鎖修飾イミダゾキノリンtlr7/8アゴニスト化合物およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US10618896B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4257198A3 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7386536B2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2951817T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019040491A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4257198A3 (en) * | 2017-08-22 | 2023-10-18 | Dynavax Technologies Corporation | Alkyl chain modified imidazoquinoline derivatives as tlr7/8 agonists and uses thereof |
| US10722591B2 (en) | 2017-11-14 | 2020-07-28 | Dynavax Technologies Corporation | Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof |
| BR112021015577A2 (pt) | 2019-02-08 | 2021-10-05 | Research & Business Foundation Sungkyunkwan University | Complexo-colesterol agonista do receptor toll-like 7 ou 8 e uso do mesmo |
| BR112022008039A2 (pt) | 2019-10-29 | 2022-07-12 | Prime Reach Trading Ltd | Compostos de 4-amino-imidazoquinolina e usos relacionados |
| CN115666637A (zh) | 2020-03-02 | 2023-01-31 | 蛋白科技先锋 | 基于病原体细胞壁骨架的模拟活病原体的纳米粒子及其制备方法 |
| EP4146204A4 (en) * | 2020-05-05 | 2024-07-03 | Virovax LLC | Vaccine adjuvants |
| EP4194008A4 (en) | 2020-08-04 | 2025-01-08 | Progeneer Inc. | Kinetically acting adjuvant ensemble |
| WO2022031021A1 (ko) | 2020-08-04 | 2022-02-10 | 성균관대학교산학협력단 | 동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신 |
| US20230277525A1 (en) | 2020-08-04 | 2023-09-07 | Progeneer Inc | Conjugate of functional drug and toll-like receptor 7 or 8 agonist of which active site is temporarily inactivated and use thereof |
| CN113967256B (zh) * | 2021-10-26 | 2022-09-30 | 山东大学 | 一种具有光热-化疗-免疫功能的纳米粒及其制备方法和应用 |
| US20250025447A1 (en) * | 2021-11-03 | 2025-01-23 | Regents Of The University Of Minnesota | Toll-like receptor agonists and antagonists and uses thereof |
| WO2023086890A1 (en) * | 2021-11-10 | 2023-05-19 | The University Of Chicago | Small molecule immunopotentiator conjugates of nfkb activators as adjuvants with enhanced efficacy and reduced toxicity |
| CN116731015B (zh) * | 2023-05-18 | 2024-09-27 | 深圳威科森生物医药科技有限公司 | 咪唑并喹啉化合物及其制备方法、应用和组合物 |
| EP4731632A1 (en) * | 2023-06-21 | 2026-04-29 | The Trustees of The University of Pennsylvania | Toll-like receptor (tlr) agonist lipidoid compounds, lipid nanoparticles (lnps) comprising the same, and methods of use thereof |
| WO2025110816A1 (ko) | 2023-11-23 | 2025-05-30 | 프로지니어 주식회사 | 암의 치료를 위한 활성화 부위가 일시적으로 비활성화된 톨-유사 수용체 7 또는 8 작용자와 항암 치료의 병용요법 |
| WO2026046400A1 (zh) * | 2024-08-30 | 2026-03-05 | 惠正奇生物技术(广州)有限公司 | 含杂芳环结构的脂质类化合物及其应用 |
| CN119320387B (zh) * | 2024-12-19 | 2025-06-27 | 杭州天龙药业有限公司 | 基于Toll样受体激动剂的疫苗佐剂脂质化合物及其应用 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL73534A (en) | 1983-11-18 | 1990-12-23 | Riker Laboratories Inc | 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds |
| DK0708772T3 (da) | 1993-07-15 | 2000-09-18 | Minnesota Mining & Mfg | Imidazo[4,5,-c]pyridin-4-aminer |
| JPH1180156A (ja) | 1997-09-04 | 1999-03-26 | Hokuriku Seiyaku Co Ltd | 1−(置換アリール)アルキル−1h−イミダゾピリジン−4−アミン誘導体 |
| UA67760C2 (uk) | 1997-12-11 | 2004-07-15 | Міннесота Майнінг Енд Мануфакчурінг Компані | Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки |
| US6180095B1 (en) | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| US6110929A (en) | 1998-07-28 | 2000-08-29 | 3M Innovative Properties Company | Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| HUP0201425A3 (en) | 1999-04-23 | 2006-07-28 | Hadasit Med Res Service | Conjugate having a cleavable linkage for use in a liposome |
| US7238368B2 (en) | 1999-04-23 | 2007-07-03 | Alza Corporation | Releasable linkage and compositions containing same |
| US6677349B1 (en) | 2001-12-21 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| WO2004032829A2 (en) | 2002-08-15 | 2004-04-22 | 3M Innovative Properties Company | Immunostimulatory compositions and methods of stimulating an immune response |
| US6818650B2 (en) | 2002-09-26 | 2004-11-16 | 3M Innovative Properties Company | 1H-imidazo dimers |
| JP2006513212A (ja) | 2002-12-20 | 2006-04-20 | スリーエム イノベイティブ プロパティズ カンパニー | アリール/ヘタリール置換されたイミダゾキノリン |
| US7387271B2 (en) | 2002-12-30 | 2008-06-17 | 3M Innovative Properties Company | Immunostimulatory combinations |
| JP2006517974A (ja) | 2003-02-13 | 2006-08-03 | スリーエム イノベイティブ プロパティズ カンパニー | Irm化合物およびトル様受容体8に関する方法および組成物 |
| AU2004229478B2 (en) | 2003-04-10 | 2009-12-24 | 3M Innovative Properties Company | Delivery of immune response modifier compounds |
| US20040265351A1 (en) | 2003-04-10 | 2004-12-30 | Miller Richard L. | Methods and compositions for enhancing immune response |
| CA2535338C (en) | 2003-08-14 | 2013-05-28 | 3M Innovative Properties Company | Substituted 1h-imidazo[4,5-c]pyridin-4-amines,1h-imidazo[4,5-c]quinolin -4-amines and 1h-imidazo[4,5-c]naphthyridin-4-amines as immune response modifiers |
| RU2006121646A (ru) | 2003-11-21 | 2008-01-10 | Новартис АГ (CH) | Производные 1h-имидазохинолина в качестве ингибиторов протеинкиназы |
| EP1765348B1 (en) | 2004-06-18 | 2016-08-03 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| WO2007079086A1 (en) | 2005-12-28 | 2007-07-12 | Coley Pharmaceutical Group, Inc. | Pyrazoloalkyl substituted imidazo ring compounds and methods |
| EP1988896A4 (en) | 2006-02-22 | 2011-07-27 | 3M Innovative Properties Co | CONJUGATES TO MODIFY IMMUNE REACTIONS |
| JP2013512859A (ja) | 2009-12-03 | 2013-04-18 | 大日本住友製薬株式会社 | トール様受容体(tlr)を介して作用するイミダゾキノリン |
| US8728486B2 (en) * | 2011-05-18 | 2014-05-20 | University Of Kansas | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds |
| US9556167B2 (en) | 2012-05-02 | 2017-01-31 | Yale University | TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs) |
| EP2674170B1 (en) | 2012-06-15 | 2014-11-19 | Invivogen | Novel compositions of TLR7 and/or TLR8 agonists conjugated to lipids |
| EP2732825B1 (en) | 2012-11-19 | 2015-07-01 | Invivogen | Conjugates of a TLR7 and/or TLR8 agonist and a TLR2 agonist |
| WO2014113634A1 (en) | 2013-01-17 | 2014-07-24 | University Of Kansas | Toll-like receptor 2-agonistic lipopeptides, and method of making the same |
| EP2769738B1 (en) | 2013-02-22 | 2016-07-20 | Invivogen | Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists |
| US10471139B2 (en) | 2013-08-15 | 2019-11-12 | The University Of Kansas | Toll-like receptor agonists |
| GB201321242D0 (en) | 2013-12-02 | 2014-01-15 | Immune Targeting Systems Its Ltd | Immunogenic compound |
| EP3092256B1 (en) | 2014-01-10 | 2022-05-18 | Birdie Biopharmaceuticals Inc. | Compounds and compositions for immunotherapy |
| SG11201608299TA (en) | 2014-05-01 | 2016-11-29 | Novartis Ag | Compounds and compositions as toll-like receptor 7 agonists |
| GB201418004D0 (en) | 2014-10-10 | 2014-11-26 | Isis Innovation | Polymer adjuvant |
| WO2017044803A1 (en) | 2015-09-09 | 2017-03-16 | The United States Of America, As Represented By The Secretary Department Of Health And Human Service | Expression vector delivery system and use thereof for inducing an immune response |
| EP3356371A4 (en) | 2015-09-29 | 2020-06-24 | The University of Chicago | POLYMER CONJUGATE VACCINE |
| CR20180229A (es) | 2015-10-29 | 2018-08-24 | Novartis Ag | Conjugados de anticuerpos que comprenden un agonista del receptor tipo toll |
| WO2018112108A1 (en) | 2016-12-13 | 2018-06-21 | Bolt Biotherapeutics, Inc. | Antibody adjuvant conjugates |
| US10328895B2 (en) | 2017-03-17 | 2019-06-25 | Autoliv Asp, Inc. | Seatbelt pretensioning retractor assembly including a pretensioner rod |
| AR111651A1 (es) | 2017-04-28 | 2019-08-07 | Novartis Ag | Conjugados de anticuerpos que comprenden agonistas del receptor de tipo toll y terapias de combinación |
| US20180311334A1 (en) | 2017-04-29 | 2018-11-01 | Yale University | Compositions and Methods for Inducing an Immune Response |
| EP4257198A3 (en) | 2017-08-22 | 2023-10-18 | Dynavax Technologies Corporation | Alkyl chain modified imidazoquinoline derivatives as tlr7/8 agonists and uses thereof |
| BR112020004505A2 (pt) | 2017-09-06 | 2020-09-15 | BioNTech SE | imidazoquinolinas substituídas como agonistas de tlr7 |
| US10722591B2 (en) | 2017-11-14 | 2020-07-28 | Dynavax Technologies Corporation | Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof |
-
2018
- 2018-08-21 EP EP23177052.0A patent/EP4257198A3/en active Pending
- 2018-08-21 ES ES18773000T patent/ES2951817T3/es active Active
- 2018-08-21 JP JP2020511364A patent/JP7386536B2/ja active Active
- 2018-08-21 US US16/107,605 patent/US10618896B2/en active Active
- 2018-08-21 EP EP18773000.7A patent/EP3672969B1/en active Active
- 2018-08-21 WO PCT/US2018/047323 patent/WO2019040491A1/en not_active Ceased
-
2020
- 2020-03-02 US US16/806,733 patent/US11124510B2/en active Active
-
2021
- 2021-08-16 US US17/403,312 patent/US11981670B2/en active Active
-
2023
- 2023-07-26 JP JP2023121658A patent/JP2023129623A/ja active Pending
-
2024
- 2024-04-08 US US18/629,809 patent/US20240368155A1/en active Pending
-
2025
- 2025-05-20 JP JP2025083816A patent/JP2025131620A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10993956B2 (en) | GLA monotherapy for use in cancer treatment | |
| JP6515182B2 (ja) | Wt1抗原ペプチドおよび免疫調節剤の併用 | |
| US12186304B2 (en) | Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint molecule | |
| JP2018508572A (ja) | 免疫チェックポイント阻害薬と併用するプリナブリンの使用 | |
| RS59134B1 (sr) | Anti-b7-h1 i anti-ctla-4 antitela za tretman nesitnoćelijskog kancera pluća | |
| JP2017515802A5 (cg-RX-API-DMAC7.html) | ||
| EP3371210B1 (en) | Combination therapy for malignant diseases | |
| JP6240083B2 (ja) | 樹状細胞癌ワクチンのための小分子エンハンサー | |
| EP3672969A1 (en) | Alkyl chain modified imidazoquinoline tlr7/8 agonist compounds and uses thereof | |
| JP2015517511A5 (cg-RX-API-DMAC7.html) | ||
| CN112351795A (zh) | 采用抗癌药剂和以包含非典型hla-i及新抗原复合物为靶点的抗体的联合抗癌疗法 | |
| JP2023539625A5 (cg-RX-API-DMAC7.html) | ||
| JP2022512384A5 (cg-RX-API-DMAC7.html) | ||
| CN111973747A (zh) | 用于联合治疗卵巢癌的喹啉衍生物 | |
| EP3976193A1 (en) | Dosing of bispecific t cell engager | |
| KR20240006683A (ko) | TLR8 조절 화합물과 항-HBV siRNA 치료제의 조합물 | |
| WO2017038997A1 (ja) | Allergin-1アンタゴニストによるがん免疫増強剤 | |
| US20210353749A1 (en) | Guanabenz as an adjuvant for immunotherapy | |
| US12090202B2 (en) | Combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases | |
| CN111328330A (zh) | 作为免疫调节剂的磷铂化合物及其治疗用途 | |
| US20160022777A1 (en) | Combination therapy with il-12 | |
| RU2026105366A (ru) | Лечение рака легкого с помощью анти-pd-1 и химиотерапии | |
| HK40015605A (en) | Method for treating cancer by combination of iap inhibitor and modulator of immune checkpoint molecule |